202 related articles for article (PubMed ID: 19131643)
1. The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration.
Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA
Am J Respir Cell Mol Biol; 2009 Aug; 41(2):179-88. PubMed ID: 19131643
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration.
Yasuoka H; Zhou Z; Pilewski JM; Oury TD; Choi AM; Feghali-Bostwick CA
Am J Pathol; 2006 Nov; 169(5):1633-42. PubMed ID: 17071587
[TBL] [Abstract][Full Text] [Related]
3. The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms.
Yasuoka H; Hsu E; Ruiz XD; Steinman RA; Choi AM; Feghali-Bostwick CA
Am J Pathol; 2009 Aug; 175(2):605-15. PubMed ID: 19628764
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5.
Yasuoka H; Garrett SM; Nguyen XX; Artlett CM; Feghali-Bostwick CA
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L644-L655. PubMed ID: 30810066
[TBL] [Abstract][Full Text] [Related]
6. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.
Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA
PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065
[TBL] [Abstract][Full Text] [Related]
7. The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells.
Seto-Young D; Zajac J; Liu HC; Rosenwaks Z; Poretsky L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3385-91. PubMed ID: 12843192
[TBL] [Abstract][Full Text] [Related]
8. The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells.
Fleming JM; Brandimarto JA; Cohick WS
J Endocrinol; 2007 Aug; 194(2):349-59. PubMed ID: 17641284
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5.
Nguyen XX; Sanderson M; Helke K; Feghali-Bostwick C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396956
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
Fu P; Liang GJ; Khot SS; Phan R; Bach LA
J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways.
Kuemmerle JF; Zhou H
J Biol Chem; 2002 Jun; 277(23):20563-71. PubMed ID: 11923300
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway.
Gleeson LM; Chakraborty C; McKinnon T; Lala PK
J Clin Endocrinol Metab; 2001 Jun; 86(6):2484-93. PubMed ID: 11397844
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells.
Hettmer S; Dannecker L; Foell J; Elmlinger MW; Dannecker GE
Hum Immunol; 2005 Feb; 66(2):95-103. PubMed ID: 15694994
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis.
Yasuoka H; Jukic DM; Zhou Z; Choi AM; Feghali-Bostwick CA
Arthritis Rheum; 2006 Sep; 54(9):3001-10. PubMed ID: 16947625
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.
Ruiz XD; Mlakar LR; Yamaguchi Y; Su Y; Larregina AT; Pilewski JM; Feghali-Bostwick CA
PLoS One; 2012; 7(8):e43049. PubMed ID: 22900087
[TBL] [Abstract][Full Text] [Related]
18. Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6.
Fu P; Thompson JA; Bach LA
J Biol Chem; 2007 Aug; 282(31):22298-306. PubMed ID: 17519236
[TBL] [Abstract][Full Text] [Related]
19. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
